Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.17M | -1.15M | -1.76M | -1.81M | -1.04M |
| Total Depreciation and Amortization | 547.10K | 535.70K | 180.50K | 185.60K | 803.30K |
| Total Amortization of Deferred Charges | -190.60K | -186.60K | 193.90K | 199.30K | -287.00K |
| Total Other Non-Cash Items | 164.00K | 160.60K | 217.60K | 223.80K | -39.90K |
| Change in Net Operating Assets | -170.70K | -167.20K | -- | -- | -648.80K |
| Cash from Operations | -824.10K | -807.00K | -1.17M | -1.20M | -1.22M |
| Capital Expenditure | -65.70K | -64.30K | -30.30K | -31.20K | -5.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.70K | -7.50K | -13.70K | -14.10K | -1.30K |
| Cash from Investing | -73.30K | -71.80K | -44.00K | -45.20K | -6.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -130.50K | -130.50K | -176.00K | -176.00K | -92.00K |
| Issuance of Common Stock | 3.08M | 3.08M | -- | -- | 3.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.89M | 1.85M | -114.70K | -117.90K | 2.39M |
| Foreign Exchange rate Adjustments | -99.00K | -96.90K | 55.70K | 57.30K | 700.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 895.90K | 877.30K | -1.27M | -1.30M | 1.17M |